Changes of allo-intestinal graft survival and intragraft cytokine expression by bone marrow augmentation with tacrolimus treatment in rats.
Nakao
A
A
First Department of Surgery, Okayama University, School of Medicine, Okayama, Japan.
Sun
D S
DS
Inagaki
M
M
Sadamori
Y
Y
Yagi
T
T
Tanaka
N
N
D000818:Animals; D016026:Bone Marrow Transplantation / Q000379:methods*; D003131:Combined Modality Therapy; D016207:Cytokines / Q000378:metabolism*; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007378:Interleukins / Q000378:metabolism; D007421:Intestine, Small / Q000637:transplantation*; D011169:Portal Vein; D051381:Rats; D011912:Rats, Inbred ACI; D011917:Rats, Inbred Lew; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D016207:Cytokines; D007166:Immunosuppressive Agents; D007378:Interleukins; D014409:Tumor Necrosis Factor-alpha; D016559:Tacrolimus